What specific types of data did FulcrumSec claim to have stolen from Novo Nordisk?

FulcrumSec claimed to have stolen more than a terabyte of data, including company source code, proprietary information on released and unreleased drugs, clinical trial data, employee and physician data, pseudonymised data of roughly 11,500 clinical trial patients, information related to company processing facilities, and internal AI model information.

Did FulcrumSec confirm whether all stolen data would be published or sold, and what exceptions did it state?

No — FulcrumSec stated it would not share certain categories of stolen data as part of its 'harm-reduction strategy', specifically withholding information on thousands of employees and physicians, data on roughly 11,500 pseudonymised clinical trial patients, and data related to operational technology and software used to interact with sensors and machinery at Novo Nordisk production facilities.

ChemBrief

Topics Daily Digest Tags

Hacking Group Claims Major Breach of Novo Nordisk, Demands $25 Million

Jun 16, 2026

Cyber extortion group FulcrumSec claims to have stolen over a terabyte of data from Novo Nordisk, including drug trial information and production facility details, after demanding a $25 million ransom.

reuters

2026-02-25

Novo Nordisk Taps Start-Up for New Oral Weight-Loss Drugs

2026-04-13

Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development

2026-04-23

Novo Nordisk's Oral GLP-1 Drug Meets Primary Goal in Late-Stage Diabetes Study

2026-05-05

Novo Nordisk's first-quarter profit beats forecasts

2026-05-26

Global Firms Bring More Work In-House at India Hubs on AI Boost